The Greek Doctor Behind the New Alzheimer’s Drug

 Σχόλιο Στρατηγού Φράγκου Φ.:

Είναι πρωτοποριακή επιστημονική επιτυχία ενος Έλληνα Γιατρού..

Είθε να συμβάλει στην θεραπεία των δυστυχισμένων συνανθρώπων μας από το Αλτσχάιμερ.

By Stacey Harris-Papaioannou

The Greek Doctor Behind the New Alzheimer’s Drug, Stelios Papadopoulos. Credit: Screenshot Youtube / Hellenic dna

Dr. Stelios Papadopoulos, the chairman at Biogen, is now offering hope for millions suffering from Alzheimer’s disease with a new drug.

The FDA has recently approved two new drugs shown to slow down the early stages of Alzheimer’s.

The first of these is Lecanameb—otherwise known as Leqembi—and the second is Aduhelm. The two were created in conjunction by the companies Eisai in Japan and Biogen in the U.S. This means that each is able to stall, if not impede, the evolution of Alzheimer’s in its earliest stages.

Διαβάστε αναλυτικά το άρθρο στην ιστοσελίδα:greekreporter.com